Grail Stock Surges 14% on Samsung-Backed Expansion into Asian Markets
Grail (GRAL) shares jumped 14.46% Thursday after announcing a strategic partnership with Samsung units to commercialize its Galleri multicancer detection product in Asia. The deal includes a $110 million equity investment from Samsung C&T and Samsung Electronics at $70.50 per share, signaling strong institutional confidence in the diagnostic technology.
The collaboration targets key Asian markets including South Korea, with Japan and Singapore flagged for future expansion. Grail's president Harpal Kumar emphasized the investment strengthens the company's balance sheet during its international push, contrasting with the broader market's 0.6% decline.